MINT-LETROZOLE

Identification of Mint-Letrozole

No description

Google image searchProduct monograph

Active ingredient

letrozole, 2.5 MG

DIN: 02508109

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MINT PHARMACEUTICALS INC

Date: 20-JUL-2021

ATC:

• L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
• L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
• L02BG — Enzyme inhibitors (ATC, ATC/DDD)
• L02BG04 — LETROZOLE (ATC/DDD)

Reference brand drug: Femara

Pharmaceutical standard: USP

External Links for Mint-Letrozole

Search on Google

• Mint-Letrozole side effects
• Mint-Letrozole dosage
• letrozole side effects
• letrozole dosage

Mint Pharmaceuticals Inc

Go to Mint website to see drug product details. Sometimes you can find mint-letrozole photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.